18 Jun, 2026
Tony Quested
London-quoted Frontier IP Group is leveraging the brainpower of Cambridge and its position as a world-renowned Science & Technology cluster to advance a game-changing proposition.
The company, which commercialises intellectual property, is developing an entire wing (18,000 sq ft) on the ground floor of the South Cambridge Science Centre in Sawston on a 20-year lease.
The master plan is to create an innovation hub, called SC2, by sub-letting top-quality lab space to its portfolio companies and other startup and early-stage technology and life science ventures. But this is no ordinary innovation space.
Frontier IP plans to customise labs to meet the specific needs of each tenant. The foundational development work it is currently undertaking will ensure the facilities are flexible enough to offer future tenants their own bespoke space.
SC2 will support Frontier IP’s growth by reinforcing its position at the heart of the Cambridge ecosystem and by extension, the broader Cambridge, Oxford, London 'Golden Triangle'. The hub will also help the Group to identify early-stage technologies and companies within the ecosystem with good commercial promise. The hub itself will then allow Frontier IP to showcase its portfolio companies and leverage relationships with both existing and new investors.
Most of the IP commercialised by AIM-quoted Frontier IP is developed initially by academics. It becomes involved at a very early stage, often identifying promising technologies while they are still in the labs.
In most cases, it becomes a founding shareholder and receives an equity stake in return for the hands-on commercialisation services it provides, rather than cash. It validates the science or technology by demonstrating that it not only works but also can be scaled up to meet market needs and demands.
Usually, it does this in partnership with external industry partners and investors. The bulk of financial investment comes from outside of Frontier IP so portfolio company valuations are underpinned by external specialists.
When companies are deemed ready Frontier IP will seek to exit, either via an IPO or trade sale. It already has one major exit on its CV - Exscientia, which generated £14 million in returns to Frontier IP in return for a cash investment of under £2,000. Exscientia's first AI-designed molecule was created for Sumitomo Pharma to treat obsessive-compulsive disorder.
With offices in the UK and Portugal and portfolio companies based in Italy and Canada, Frontier IP is one of the UK's powers behind many thrones. The nature of its business means it doesn't have customers directly. However, its portfolio companies are supported by a broad range of industry partners and investors.
Examples include 2D Photonics, which has raised funding from the Nato Innovation Fund, the Sony Innovation Fund, Bosch Ventures, CDP Venture, Indaco Ventures and Join Capital; Alusid, whose customers include Topps Tiles, Starbucks EMEA and continental distributors such as Kakelspecialisten AB, part of Saint-Gobain, FRONT Materials and 3D Wall Panels Italia.
GraphEnergyTech is backed by Aramco Ventures, the corporate venturing arm of Aramco, and is collaborating with Taiwan Perovskite Solar Corporation, the Taiwanese Industrial Technology Research Institute and the University of Cambridge to develop next-generation solar technologies. Frontier IP stresses that the list does not cover all of its portfolio businesses but offers an insight to the type of company it chooses to back and nurture.
Funded via equity fundraisings and the proceeds of selling shares in its portfolio companies - either through initial public offerings or trade sales - Frontier IP was analytical in choosing South Cambs as a potential launchpad to further global growth.
Chief Executive Neil Crabb says: “Cambridge is one of the world’s leading universities for developing the deep, fundamental technologies and life sciences in which we specialise. Having our own innovation hub based at the SCSC reinforces our position within the Cambridge ecosystem and the networks beyond that it taps into, including the Cambridge, Oxford, London Golden Triangle.
“In terms of the SCSC, we were attracted because of the opportunity it gave us to create dedicated, state of the art labs for portfolio companies and potential portfolio companies in a new build site at the heart of the Cambridge ecosystem.
“I am excited by the possibilities offered by SC2. I believe it will provide a basis to transform Frontier IP's growth potential by providing a highly-attractive space and custom facilities to our existing portfolio companies and other potential start-ups and early-stage companies.
“Because it sits at the centre of Cambridge's investor and science and technology networks, the hub will enable us to accelerate the development and scale up of our existing portfolio companies and potential portfolio companies and their progress towards successful exits.”
Source: https://www.businessweekly.co.uk/posts/fresh-frontiers-as-ip-power-player-takes-academic-excellence-to-the-world
Tony Quested
tquested@businessweekly.co.uk
https://www.linkedin.com/in/tony-quested-1baa455/